Health Priorities | Diabetes, Diet, GLP-1 RAS
In 2021, the prevalence of type 2 diabetes (T2D) rose to an estimated 38.4 million adults (nearly 15% of US adults). 1. The American Diabetes Association (ADA) standards for diabetes…
In 2021, the prevalence of type 2 diabetes (T2D) rose to an estimated 38.4 million adults (nearly 15% of US adults). 1. The American Diabetes Association (ADA) standards for diabetes…
What is GLP-1? For who is it? What do you need to know about it before you talk to your doctor? Read the answer! I know that many of our…
In this week’s issue of The Savvy Diabetic: FDA Approves Kristy – Biosimilar to Novolog Dexcom Responds to Sensor Failures & More ‘Ozempic Teeth’ GLP-1 Side Effect Innovations in Preventing/Treating…
Among patients with type 1 diabetes with GLP-1SWE, we found that there is less likelihood of diabetic complications in the grand study among patients with T1D who have no history…
In this week’s issue of The Savvy Diabetic: 1st Rapid-Acting Biosimilar Insulin Approved UVa AI-Powered Insulin Delivery Susvimo for Diabetic Macular Edema Oral Insulin Prevention Trial (PDF) GLP-1 Agonists Increased…
(Health Day News)-In the case of diabetes patients who have undergone surgical treatment, the active percherative peptide-1 receptor agonist (GLP-1 RA) prescription is re-hospitalized after the risk adjustment, wound detachment,…
The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), significantly improving access to diabetes treatment. Glucagon-like peptide-1 (GLP-1) receptor agonists are designed to…
Top Line Use of GLP-1 drugs such as semaglutide for weight loss has doubled in the past decade, but uptake among people with type 2 diabetes has declined, according to…
Add a topic to an email alert Get emails when new articles are published Enter your email address to receive emails when new articles are published.…
health Source: RFstudio/Pexels There has been some controversy over the use of a class of drugs known as GLP-1 agonists to treat obesity. GLP-1 agonists, also known as GLP-1, are…